These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 26191134)

  • 21. Salvage combination intravesical immunotherapy with Bacillus Calmette-Guérin and interferon-α2B: impact on recurrence, progression, and survival.
    Prasad SM; Eyre S; Loughlin KR
    Hosp Pract (1995); 2013; 41(4):31-9. PubMed ID: 24145587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravesical bacillus Calmette-Guérin efficiently reduces p70S6K1 but not 4E-BP1 phosphorylation in nonmuscle invasive bladder cancer.
    Ferrari KL; de Camargo JA; Rocha GZ; Carvalheira JB; Saad MJ; Billis A; Reis LO
    J Urol; 2015 Feb; 193(2):682-9. PubMed ID: 25200808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. OncoTherad® (MRB-CFI-1) nano-immunotherapy reduced tumoral progression in non-muscle invasive bladder cancer through activation of Toll-like signaling pathway.
    Reis IB; Tibo LHS; Socca EAR; de Souza BR; Durán N; Fávaro WJ
    Tissue Cell; 2022 Jun; 76():101762. PubMed ID: 35245856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacillus Calmette-Guérin strain differences have an impact on clinical outcome in bladder cancer immunotherapy.
    Rentsch CA; Birkhäuser FD; Biot C; Gsponer JR; Bisiaux A; Wetterauer C; Lagranderie M; Marchal G; Orgeur M; Bouchier C; Bachmann A; Ingersoll MA; Brosch R; Albert ML; Thalmann GN
    Eur Urol; 2014 Oct; 66(4):677-88. PubMed ID: 24674149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor.
    Yoon HG; Wong J
    Mol Endocrinol; 2006 May; 20(5):1048-60. PubMed ID: 16373395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex Hormone Receptor Signaling in Bladder Cancer: A Potential Target for Enhancing the Efficacy of Conventional Non-Surgical Therapy.
    Ide H; Miyamoto H
    Cells; 2021 May; 10(5):. PubMed ID: 34064926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of P-MAPA Immunomodulator on Toll-Like Receptors and p53: Potential Therapeutic Strategies for Infectious Diseases and Cancer.
    Fávaro WJ; Nunes OS; Seiva FR; Nunes IS; Woolhiser LK; Durán N; Lenaerts AJ
    Infect Agent Cancer; 2012 Jun; 7(1):14. PubMed ID: 22709446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of androgen receptor in non-muscle-invasive bladder cancer predicts the preventive effect of androgen deprivation therapy on tumor recurrence.
    Izumi K; Ito Y; Miyamoto H; Miyoshi Y; Ota J; Moriyama M; Murai T; Hayashi H; Inayama Y; Ohashi K; Yao M; Uemura H
    Oncotarget; 2016 Mar; 7(12):14153-60. PubMed ID: 26885620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Androgen receptor signals regulate UDP-glucuronosyltransferases in the urinary bladder: a potential mechanism of androgen-induced bladder carcinogenesis.
    Izumi K; Zheng Y; Hsu JW; Chang C; Miyamoto H
    Mol Carcinog; 2013 Feb; 52(2):94-102. PubMed ID: 22086872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TLR4- and TLR9-dependent effects on cytokines, cell viability, and invasion in human bladder cancer cells.
    Olbert PJ; Kesch C; Henrici M; Subtil FS; Honacker A; Hegele A; Hofmann R; Hänze J
    Urol Oncol; 2015 Mar; 33(3):110.e19-27. PubMed ID: 25499923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of flutamide on expression of androgen and estrogen receptors in the gubernaculum and surrounding structures during testicular descent.
    Nation TR; Buraundi S; Balic A; Farmer PJ; Newgreen D; Southwell BR; Hutson JM
    J Pediatr Surg; 2011 Dec; 46(12):2358-62. PubMed ID: 22152882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacillus Calmette-Guérin immunotherapy for genitourinary cancer.
    Gandhi NM; Morales A; Lamm DL
    BJU Int; 2013 Aug; 112(3):288-97. PubMed ID: 23517232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New synthetic nano-immunotherapy (OncoTherad®) for non-muscle invasive bladder cancer: Its synthesis, characterization and anticancer property.
    Fávaro WJ; Alonso JCC; de Souza BR; Reis IB; Gonçalves JM; Deckmann AC; Oliveira G; Dias QC; Durán N
    Tissue Cell; 2023 Feb; 80():101988. PubMed ID: 36521234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histopathological and prognostic significance of the expression of sex hormone receptors in bladder cancer: A meta-analysis of immunohistochemical studies.
    Ide H; Inoue S; Miyamoto H
    PLoS One; 2017; 12(3):e0174746. PubMed ID: 28362839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of intravesical immunotherapy on sperm parameters in young patients with non--muscle-invasive bladder carcinoma: prospective analysis.
    Garg M; Sankhwar SN; Goel A; Kumar M; Singh BP; Singh V; Dalela D; Kumar A; Paul S
    Clin Genitourin Cancer; 2014 Jun; 12(3):e83-6. PubMed ID: 24411194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficacy of intravesical bacillus Calmette-Guerin in the treatment of patients with pT1 stage non-muscle-invasive bladder cancer.
    Ajili F; Darouiche A; Chebil M; Boubaker S
    Ultrastruct Pathol; 2013 Aug; 37(4):278-83. PubMed ID: 23789613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of bacillus Calmette-Guerin refractory non-muscle invasive bladder cancer.
    Turker P; Turkeri L
    Arch Esp Urol; 2013 Nov; 66(9):833-40. PubMed ID: 24231293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Androgen Receptor Signaling Reduces Radiosensitivity in Bladder Cancer.
    Ide H; Inoue S; Mizushima T; Jiang G; Chuang KH; Oya M; Miyamoto H
    Mol Cancer Ther; 2018 Jul; 17(7):1566-1574. PubMed ID: 29720561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer.
    Biot C; Rentsch CA; Gsponer JR; Birkhäuser FD; Jusforgues-Saklani H; Lemaître F; Auriau C; Bachmann A; Bousso P; Demangel C; Peduto L; Thalmann GN; Albert ML
    Sci Transl Med; 2012 Jun; 4(137):137ra72. PubMed ID: 22674550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravesical therapy for bladder cancer.
    Williams SK; Hoenig DM; Ghavamian R; Soloway M
    Expert Opin Pharmacother; 2010 Apr; 11(6):947-58. PubMed ID: 20205607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.